Availability of monoclonal antibody treatment for mild to moderate COVID is limited in Canada based on medication supply and availability of dedicated infusion centres and staff in some parts of the country.

Medical Mythbusting Commentary for October 26, 2021


Regeneron’s antibody COVID-19 treatment is popular in the U.S. — why not in Canada?
Doctors are often unaware of the only treatment for early Covid-19